These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 25811461)

  • 1. Instability in the COPD diagnosis upon repeat testing vary with the definition of COPD.
    Perez-Padilla R; Wehrmeister FC; Montes de Oca M; Lopez MV; Jardim JR; Muino A; Valdivia G; Pertuze J; Menezes AM;
    PLoS One; 2015; 10(3):e0121832. PubMed ID: 25811461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Utility of normality low limit of spirometry in diagnosed COPD patients].
    Naveiro-Rilo JC; García García S; Flores-Zurutuza L; Carazo Fernández L; Domínguez Fernández C; Palomo García JL
    Rev Calid Asist; 2017; 32(5):262-268. PubMed ID: 28863965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of diagnostic criteria on the prevalence of COPD.
    Çolak Y; Løkke A; Marott JL; Lange P; Vestbo J
    Clin Respir J; 2013 Jul; 7(3):297-303. PubMed ID: 23072716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the U.S. prevalence of chronic obstructive pulmonary disease using pre- and post-bronchodilator spirometry: the National Health and Nutrition Examination Survey (NHANES) 2007-2010.
    Tilert T; Dillon C; Paulose-Ram R; Hnizdo E; Doney B
    Respir Res; 2013 Oct; 14(1):103. PubMed ID: 24107140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower limit of normal or FEV1/FVC < 0.70 in diagnosing COPD: an evidence-based review.
    Mohamed Hoesein FA; Zanen P; Lammers JW
    Respir Med; 2011 Jun; 105(6):907-15. PubMed ID: 21295958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliability of FEV1/FEV6 to diagnose airflow obstruction compared with FEV1/FVC: the PLATINO longitudinal study.
    Perez-Padilla R; Wehrmeister FC; Celli BR; Lopez-Varela MV; Montes de Oca M; Muiño A; Talamo C; Jardim JR; Valdivia G; Lisboa C; Menezes AM;
    PLoS One; 2013; 8(8):e67960. PubMed ID: 23936297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Misidentification of airflow obstruction: prevalence and clinical significance in an epidemiological study.
    Pothirat C; Chaiwong W; Phetsuk N; Liwsrisakun C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():535-40. PubMed ID: 25792821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical impact of the lower limit of normal of FEV
    Liu S; Zhou Y; Liu S; Zou W; Li X; Li C; Deng Z; Zheng J; Li B; Ran P
    Respir Med; 2018 Jun; 139():27-33. PubMed ID: 29857998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?
    Kjeldgaard P; Dahl R; Løkke A; Ulrik CS
    Int J Chron Obstruct Pulmon Dis; 2015; 10():407-14. PubMed ID: 25759573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic accuracy of pre-bronchodilator FEV1/FEV6 from microspirometry to detect airflow obstruction in primary care: a randomised cross-sectional study.
    van den Bemt L; Wouters BC; Grootens J; Denis J; Poels PJ; Schermer TR
    NPJ Prim Care Respir Med; 2014 Aug; 24():14033. PubMed ID: 25119686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the impact of different spirometric criteria on the prevalence of spirometrically defined COPD and its comorbidities? Results from the population-based KORA study.
    Karrasch S; Brüske I; Smith MP; Thorand B; Huth C; Ladwig KH; Kronenberg F; Heinrich J; Holle R; Peters A; Schulz H
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1881-94. PubMed ID: 27574413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of chronic obstructive pulmonary disease in Riyadh, Saudi Arabia: a BOLD study.
    Al Ghobain M; Alhamad EH; Alorainy HS; Al Kassimi F; Lababidi H; Al-Hajjaj MS
    Int J Tuberc Lung Dis; 2015 Oct; 19(10):1252-7. PubMed ID: 26459542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FEV1/FEV6 is effective as a surrogate for FEV1/FVC in the diagnosis of chronic obstructive pulmonary disease.
    Venkatachalam P; Dwivedi DP; Govindraj V
    Indian J Tuberc; 2021 Apr; 68(2):230-235. PubMed ID: 33845957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relevance of fixed ratio vs lower limit of normal of FEV1/FVC in COPD: patient-reported outcomes from the CanCOLD cohort.
    van Dijk W; Tan W; Li P; Guo B; Li S; Benedetti A; Bourbeau J;
    Ann Fam Med; 2015; 13(1):41-8. PubMed ID: 25583891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "GOLD or lower limit of normal definition? A comparison with expert-based diagnosis of chronic obstructive pulmonary disease in a prospective cohort-study".
    Güder G; Brenner S; Angermann CE; Ertl G; Held M; Sachs AP; Lammers JW; Zanen P; Hoes AW; Störk S; Rutten FH
    Respir Res; 2012 Feb; 13(1):13. PubMed ID: 22309369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics of patients newly diagnosed with COPD by the fixed ratio and lower limit of normal criteria: a cross-sectional analysis of the TargetCOPD trial.
    Miller MR; Haroon S; Jordan RE; Sitch AJ; Dickens AP; Enocson A; Fitzmaurice DA; Adab P
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1979-1986. PubMed ID: 29950827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung function, forced expiratory volume in 1 s decline and COPD hospitalisations over 44 years of follow-up.
    Zaigham S; Wollmer P; Engström G
    Eur Respir J; 2016 Mar; 47(3):742-50. PubMed ID: 26647443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COPD Underdiagnosis and Misdiagnosis in a High-Risk Primary Care Population in Four Latin American Countries. A Key to Enhance Disease Diagnosis: The PUMA Study.
    Casas Herrera A; Montes de Oca M; López Varela MV; Aguirre C; Schiavi E; Jardim JR;
    PLoS One; 2016; 11(4):e0152266. PubMed ID: 27073880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of FEV
    Yee N; Markovic D; Buhr RG; Fortis S; Arjomandi M; Couper D; Anderson WH; Paine R; Woodruff PG; Han MK; Martinez FJ; Barr RG; Wells JM; Ortega VE; Hoffman EA; Kim V; Drummond MB; Bowler RP; Curtis JL; Cooper CB; Tashkin DP; Barjaktarevic IZ
    Chest; 2022 Apr; 161(4):949-959. PubMed ID: 34767825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FEV1/FEV6 and FEV6 as an alternative for FEV1/FVC and FVC in the spirometric detection of airway obstruction and restriction.
    Vandevoorde J; Verbanck S; Schuermans D; Kartounian J; Vincken W
    Chest; 2005 May; 127(5):1560-4. PubMed ID: 15888828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.